These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 1981700)

  • 1. Expressing the specificity and the potency of cytochrome P-450 inducers toward 7-ethoxyresorufin.
    Paolini M; Forti GC; Bauer C
    Drug Metab Dispos; 1990; 18(5):551. PubMed ID: 1981700
    [No Abstract]   [Full Text] [Related]  

  • 2. Benzyloxyresorufin as a specific substrate for the major phenobarbital-inducible dog liver cytochrome P450 (P4502B11).
    Klekotka PA; Halpert JR
    Drug Metab Dispos; 1995 Dec; 23(12):1434-5. PubMed ID: 8689957
    [No Abstract]   [Full Text] [Related]  

  • 3. [Relation between the 7-ethoxyresorufin-O-deethylase activity of the liver microsomal monooxygenase system and the level of methylcholanthrene-induced form of cytochrome P-450].
    Grishanova AIu; Peregoedova EL; Mishin VM; Liakhovich VV
    Biokhimiia; 1988 Jun; 53(6):956-9. PubMed ID: 3179354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of 7-ethoxyresorufin by phenobarbital or Aroclor 1254 pretreated mice.
    Glass SJ; van Lier RB
    Drug Metab Dispos; 1988; 16(2):333-4. PubMed ID: 2898358
    [No Abstract]   [Full Text] [Related]  

  • 5. Ethoxyresorufin: direct fluorimetric assay of a microsomal O-dealkylation which is preferentially inducible by 3-methylcholanthrene.
    Burke MD; Mayer RT
    Drug Metab Dispos; 1974; 2(6):583-8. PubMed ID: 4155680
    [No Abstract]   [Full Text] [Related]  

  • 6. The effects of selective cytochrome P-450 inducing agents on trimethadione metabolism as an indicator of hepatic drug-oxidizing capacity in rats.
    Tanaka E; Etoh H; Misawa S
    Res Commun Chem Pathol Pharmacol; 1990 Jun; 68(3):375-8. PubMed ID: 2385760
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of model inducers on cytochrome P450 activities of human hepatocytes in primary culture.
    Donato MT; Castell JV; Gómez-Lechón MJ
    Drug Metab Dispos; 1995 May; 23(5):553-8. PubMed ID: 7587930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Directed modification of the structure of cytochrome P-450 substrates as a method of generating new inducers of the microsomal monooxygenase system].
    Tsyrlov IB; Gerasimov KE; Gutkina NI; Liakhovich VV
    Biokhimiia; 1987 Aug; 52(8):1307-14. PubMed ID: 3663765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Content of cytochrome P-450 and its induction capacity in primary liver tumors in rats].
    Koliada AIu; Gel'shteĭn VI; Kobliakov VA
    Biull Eksp Biol Med; 1988 Feb; 105(2):198-200. PubMed ID: 3349151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of the inducing action of aroclor 1254 in rats in long-term experiment].
    Piekoszewski W; Brandys J; Lipniak M
    Folia Med Cracov; 1990; 31(3):201-7. PubMed ID: 2097286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The comparative potency of phenobarbital and five 1,3-propanediol dicarbamates for hepatic cytochrome P450 induction in rats.
    Segelman FH; Kelton E; Terzi RM; Kucharczyk N; Sofia RD
    Res Commun Chem Pathol Pharmacol; 1985 Jun; 48(3):467-70. PubMed ID: 4023427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of cytochrome P450-inducers on promutagen activation capabilities and enzymatic activities of S-9 from rat liver.
    Ong T; Mukhtar M; Wolf CR; Zeiger E
    J Environ Pathol Toxicol; 1980 Aug; 4(1):55-65. PubMed ID: 7441130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The sequelae of cytochrome P-450 induction].
    Lukienko PI; Zavodnik LB; Bushma MI
    Eksp Klin Farmakol; 1995; 58(1):68-73. PubMed ID: 7787705
    [No Abstract]   [Full Text] [Related]  

  • 14. Regulation of hepatic monooxygenases by phenobarbital, 3-methylcholanthrene, and polychlorinated biphenyls in rapid and slow acetylator mice.
    Elves RG; Ueng TH; Alvares AP
    Drug Metab Dispos; 1985; 13(3):354-8. PubMed ID: 2861996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Species differences in phenytoin induction of cytochrome P450 due to pharmacokinetic differences.
    Billings RE; Hansen DK
    Proc West Pharmacol Soc; 1984; 27():539-42. PubMed ID: 6494195
    [No Abstract]   [Full Text] [Related]  

  • 16. Lack of constitutive and inducible ethoxyresorufin-O-deethylase activity in the liver of suckermouth armored catfish (Hypostomus affinis and Hypostomus auroguttatus, Loricariidae).
    Parente TE; De-Oliveira AC; Beghini DG; Chapeaurouge DA; Perales J; Paumgartten FJ
    Comp Biochem Physiol C Toxicol Pharmacol; 2009 Aug; 150(2):252-60. PubMed ID: 19460462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative pharmacodynamics of hepatic cytochrome P450 2B induction by 5,5-diphenyl- and 5,5-diethyl-substituted barbiturates and hydantoins in the male F344/NCr rat.
    Nims RW; McClain RM; Manchand PS; Belica PS; Thomas PE; Mellini DW; Utermahlen WE; Lubet RA
    J Pharmacol Exp Ther; 1994 Jul; 270(1):348-55. PubMed ID: 8035330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitation of hepatic cytochrome P1-450 mRNA with the use of a cloned DNA probe. Effects of various P-450 inducers in C57BL/6N and DBA/2N mice.
    Tukey RH; Negishi M; Nebert DW
    Mol Pharmacol; 1982 Nov; 22(3):779-86. PubMed ID: 7155135
    [No Abstract]   [Full Text] [Related]  

  • 19. Acetaminophen toxicity in cultured trout liver cells. II. Maintenance of cytochrome P450 1A1.
    Miller MR; Saito N; Blair JB; Hinton DE
    Exp Mol Pathol; 1993 Apr; 58(2):127-38. PubMed ID: 8495716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the microsomal cytochrome P-450 species induced in rat liver by 2-acetylaminofluorene.
    Aström A; Meijer J; DePierre JW
    Cancer Res; 1983 Jan; 43(1):342-8. PubMed ID: 6291757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.